|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Petros Pharmaceuticals, Inc. (PTPI) |
|
|
$0.41 0.00 (0.00%) as of 4:30 Wed 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
2,070,000 |
| Market
Cap: |
850.98(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4111 - $0.4111 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Petros Pharmaceuticals is a pharmaceutical company focused on men's health therapeutics. Co.'s operating segments are Prescription Medications and Medical Devices, which focus on the treatment of male erectile dysfunction (ED). The Prescription Medications segment consists primarily of Stendra®, which is a PDE-5 inhibitor prescription medication for the treatment of ED, and H100™, which is a topical formulation candidate for the treatment of Peyronie's disease. The Medical Devices segment consists primarily of vacuum erection devices, which are sold domestically and internationally.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boctor Fady |
See Remarks |
• – – |
2023-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
49,645 |
49,645 |
|
- |
|
| Bernstein Bruce |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,050 |
8,346 |
|
- |
|
| Walker Wayne Remell |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,050 |
8,314 |
|
- |
|
| Silverman Joshua |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,722 |
11,237 |
|
- |
|
| Bradley Greg |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,050 |
8,314 |
|
- |
|
| Walker Wayne Remell |
Director |
– • – |
2023-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,264 |
2,264 |
|
- |
|
| Bradley Greg |
Director |
– • – |
2023-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,264 |
2,264 |
|
- |
|
| Bernstein Bruce |
Director |
– • – |
2023-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,264 |
2,296 |
|
- |
|
| Silverman Joshua |
Director |
– • – |
2023-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,515 |
4,515 |
|
- |
|
| Juggernaut Partners Iii Gp, Ltd. |
10% Owner |
– – • |
2021-12-22 |
4 |
B |
$3.43 |
$500,001 |
I/I |
145,773 |
5,703,544 |
1.5 |
-64% |
|
| Juggernaut Partners Iii Gp, Ltd. |
10% Owner |
– – • |
2021-11-29 |
4 |
B |
$3.00 |
$1,500,000 |
I/I |
500,000 |
5,557,771 |
1.5 |
-71% |
|
| Juggernaut Partners Iii Gp, Ltd. |
10% Owner |
– – • |
2021-10-18 |
4 |
B |
$1.72 |
$2,849,999 |
I/I |
1,661,807 |
5,057,771 |
1.5 |
-18% |
|
| Juggernaut Partners Iii Gp, Ltd. |
10% Owner |
– – • |
2020-12-01 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
100 |
|
- |
|
| Metuchen Therapeutics, Llc |
10% Owner |
– – • |
2020-12-01 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,395,964 |
3,395,964 |
|
- |
|
| Lavan Keith |
Chief Financial Officer |
• – – |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
I/I |
975 |
975 |
|
- |
|
| Shulman John D |
Director |
– • • |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
I/I |
3,382,416 |
3,382,416 |
|
- |
|
| Gesek Andrew |
President, Timm Medical |
• – – |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
I/I |
97 |
97 |
|
- |
|
| Bernstein Bruce |
Director |
– • – |
2020-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
313 |
|
- |
|
| Silverman Joshua |
Director |
– • – |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| Shulman John D |
Director |
– • • |
2020-12-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100 |
|
- |
|
| Arnold Mitchell |
Prin. Acct. Off/Prin. Fin. Off |
• – – |
2020-01-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
390 |
|
- |
|
| Arnold Mitchell |
Prin. Acct. Off/Prin. Fin. Off |
• – – |
2020-01-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
779 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
